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retrospectivelygatheredandprospectively analyzed forprocedural success
(reduction in LVOT gradient) and procedural complications.
RESULTS There were 298 males (5313y) and 347 females (6015.5y).
The male cohort received a higher dose of alcohol; however, there
were no other differences in procedural success, mortality, or need for
permanent pacemaker implantation. (Table 1) There were 555
Caucasian (5715y) and 59 African American (5915y) patients in the
study. African American patients had more septal arteries injected
with more alcohol, a higher post ablation creatinine kinase level,
and a greater reduction in peak LVOT gradient compared to the
Caucasian cohort. There was no difference in procedural mortality
or the need for permanent pacemaker. (Table 2)Male (STD; CI; or
number of
incident)Female (STD; CI;
or number of
incident)P value for
genderCaucasian (STD;
CI; or number of
incident)African American
(STD; CI; or
number of
incident) P value for raceN 298 347 NA 555 59 NAAge 53 (14; þ/- 1.5) 60 (15.5; þ/- 1.6) 0.0000000056 57 (15; þ/- 1.25) 59 (14; þ/- 4) 0.3Reduction in
Gradient87 (51; þ/- 6.14) 84 (54.8; þ/- 6.1) 0.85 84 (50; þ/- 4.5) 99 (55; þ/- 16) 0.05Number of
Septal
Arteries
Injected1.16 (0.4; þ/-
0.05)1.16 (0.45; þ/-
0.05)0.96 1.15 (0.4; þ/-
0.03)1.26 (0.5; þ/-
0.13)0.05Amount of
EtHO
Injected2.27 (0.7; þ/-
0.08)2.14 (0.76; þ/-
0.08)0.03 2.2 (0.74; þ/-
0.06)2.34 (0.7; þ/-
0.2)0.09Peak Creatinine
Kinase1194 (701; þ/- 81) 1082 (790; þ/-
85)0.06 1099 (765; þ/-
65)1426 (646; þ/-
170)0.001Rate of Heart
Block
Requiring
PPM6 % (18 of 298) 6.9% (24 of 347) 0.65 6.3 % (35 of 555) 8.5% (5 of 59) 0.52Procedural
Death1% (2 of 298) 1.2 % (4 of 347) 0.52 0.9% (5 of 555) 1.7 % (1 of 59) 0.55CONCLUSIONS There was no signiﬁcant effect of gender on the out-
comes of alcohol septal ablation. Despite the need for more septals
injected and ahigher alcohol dose (larger infarct size) inAfricanAmerican
patients, the clinical outcomes were similar to the Caucasian cohort. The
higher alcohol dose and infarct size likely reﬂects the greater septal hy-
pertrophy typically seen in African American patients with HOCM.
CATEGORIES STRUCTURAL: Alcohol Septal Ablation/HOCM
KEYWORDS Ablation, alcohol septal, Hypertrophic obstructive car-
diomyopathy, Racial disparities
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New Orleans, USABACKGROUND Several randomized controlled trials (RCTs) have
shown inconsistent results in regards to outcomes in patients with
acute ischemic stroke (AIS) undergoing endovascular therapy (ET)
versus standard medical treatment (MT). Thus we sought to evaluate
the effectiveness and safety of ET compared to MT in patients with
AIS utilizing data from all available RCTs.
METHODS We conducted electronic searches of RCT. The primary
efﬁcacy endpoints were modiﬁed Rankin scale 0 to 2, recurrent stroke,
and all-cause mortality. Safety endpoints included intracranial hem-
orrhage (ICH) and all-bleeding events. Odds ratios (OR) and 95%
conﬁdence intervals (CI) computed using the Mantel-Haenszel
method. Random-effect model was used. Sensitivity analysis and bias
quantiﬁcation were also assessed.
RESULTS Ten RCTs were included, with a total of 2,716 patients. There
was a signiﬁcant difference favoring ET compared to MT for modiﬁed
Rankin scale score 0 to 2 (OR: 0.62; 95% CI: 0.44 to 0.86; p< 0.01). We
found no difference between ET vs. MT for all-cause mortality (OR:
0.92; 95% CI: 0.74 to 1.14; p¼ 0.42) and recurrent stroke (OR: 1.82; 95%
CI: 0.79 to 4.16; p¼ 0.16). For safety outcomes, there was an increased
risk of all-bleeding events (OR: 1.91; 95% CI: 1.22 to 3.00; p< 0.01) and
ICH (OR: 1.95; 95% CI: 1.24 to 3.06; p< 0.01) following ET. Sensitivity
analysis of one study removal showed that exclusion of the PROACT II
study from the analysis for all-bleeding and ICH outcomes changed the
ﬁnal effect to a non-signiﬁcant difference between both approaches.
No evidence of publication bias was observed. The number needed to
treat for a Rankin score 0 to 2 is 8; the number needed to harm for all-
bleeding and ICH is 8 and 10 respectively.
CONCLUSIONS The results of this meta-analysis indicate that in pa-
tients with AIS, ET is superior to standard MT for disability-free sur-
vival, with an increased risk of bleeding and ICH.
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BACKGROUND We retrospectively analyzed data from our center to
quantify complication rates in patients undergoing carotid artery stent-
ing (CAS). Thereby, we sought to evaluate a possible association between
the vessel (left vs. right) treated and the respective complication rate.
METHODS In a retrospective analysis of 1124 consecutive patients
(pts) undergoing CAS at our institution between December 1997 and
January 2015, 557 pts (49,6%) underwent stenting of the left carotid
artery (group 1) and 567 pts (50,4%) of the right carotid artery (group
2). Thirteen patients with a simultaneous intervention of both carotid
arteries were excluded from our analysis. The baseline data of both
groups were similar (mean age 71.4  38.9 years, 175 females (31.4%)
in group 1 versus mean age of 71.9  39.1 years and 189 females (33.3%)
in group 2; no differences in comorbidities).
RESULTS CAS was successful in all but 32 patients (13 [2.3%] of them in
group 1, and 19 [3.6%] in group 2, p¼ns). The mean degree of stenosis
was reduced from 85.5 10.3% to 3.1 6.4% in group 1, and 85.9 9.6%
to 3.5 7.3% in group 2, respectively (p¼ns). Themean stent lengthwas
27.9  6.7 mm in group 1 and 27.5  9.8 mm in group 2 (p¼ns), and the
mean procedure timewas not different between both groups (17.2 11.4
